These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19086029)

  • 1. O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program.
    Francisco H; Kollins K; Varghis N; Vocadlo D; Vosseller K; Gallo G
    Dev Neurobiol; 2009 Feb 1-15; 69(2-3):162-73. PubMed ID: 19086029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-linked beta-N-acetylglucosaminylation in mouse embryonic neural precursor cells.
    Yanagisawa M; Yu RK
    J Neurosci Res; 2009 Dec; 87(16):3535-45. PubMed ID: 19598243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death.
    Ngoh GA; Hamid T; Prabhu SD; Jones SP
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1711-9. PubMed ID: 19734355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase.
    Macauley MS; Vocadlo DJ
    Biochim Biophys Acta; 2010 Feb; 1800(2):107-21. PubMed ID: 19664691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
    Johnson B; Opimba M; Bernier J
    Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
    Park SY; Ryu J; Lee W
    Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAc modification of proteins affects volume regulation in Jurkat cells.
    Nagy T; Balasa A; Frank D; Rab A; Rideg O; Kotek G; Magyarlaki T; Bogner P; Kovács GL; Miseta A
    Eur Biophys J; 2010 Jul; 39(8):1207-17. PubMed ID: 20043149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc modification modulates the expression of osteocalcin via OSE2 and Runx2.
    Kim SH; Kim YH; Song M; An SH; Byun HY; Heo K; Lim S; Oh YS; Ryu SH; Suh PG
    Biochem Biophys Res Commun; 2007 Oct; 362(2):325-9. PubMed ID: 17707335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane.
    Chun YS; Park Y; Oh HG; Kim TW; Yang HO; Park MK; Chung S
    J Alzheimers Dis; 2015; 44(1):261-75. PubMed ID: 25208619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyper-O-GlcNAcylation inhibits the induction of heat shock protein 70 (Hsp 70) by sodium arsenite in HeLa cells.
    Miura Y; Sato T; Sakurai Y; Sakai R; Hiraoka W; Endo T
    Biol Pharm Bull; 2014; 37(8):1308-14. PubMed ID: 25087952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
    Vosseller K; Wells L; Lane MD; Hart GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics.
    Vosseller K; Wells L; Hart GW
    Biochimie; 2001 Jul; 83(7):575-81. PubMed ID: 11522385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAc expression in developing and ageing mouse brain.
    Rex-Mathes M; Werner S; Strutas D; Griffith LS; Viebahn C; Thelen K; Schmitz B
    Biochimie; 2001 Jul; 83(7):583-90. PubMed ID: 11522386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.
    Arias EB; Kim J; Cartee GD
    Diabetes; 2004 Apr; 53(4):921-30. PubMed ID: 15047606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells.
    Matthews JA; Acevedo-Duncan M; Potter RL
    Biochim Biophys Acta; 2005 Apr; 1743(3):305-15. PubMed ID: 15843043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo.
    Ranuncolo SM; Ghosh S; Hanover JA; Hart GW; Lewis BA
    J Biol Chem; 2012 Jul; 287(28):23549-61. PubMed ID: 22605332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
    Gao Y; Parker GJ; Hart GW
    Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1.
    Gandy JC; Rountree AE; Bijur GN
    FEBS Lett; 2006 May; 580(13):3051-8. PubMed ID: 16684529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.